Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Shanghai Zerun Biotechnology Co.,Ltd
ClinicalTrials.gov Identifier:
NCT01548118
First received: February 29, 2012
Last updated: March 5, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)